Research Article

Thirteen-Week Oral Toxicity Study of HVC1 in Rats

Table 4

Hematological and plasma coagulation values of HVC1-treated male rats.

Test item (unit)Treatment group (mg/kg/day)
Control5001,0002,000

WBC (K/μL)9.86 ± 1.779.01 ± 2.4111.78 ± 11.71 ±
Neutrophil (K/μL)1.64 ± 0.681.47 ± 0.421.92 ± 0.491.34 ± 0.38
Lymphocyte (K/μL)7.83 ± 1.657.12 ± 2.059.35 ± 2.139.92 ± 2.82
Monocyte (K/μL)0.21 ± 0.070.24 ± 0.080.29 ± 0.080.25 ± 0.10
Eosinophil (K/μL)0.08 ± 0.030.07 ± 0.020.08 ± 0.030.07 ± 0.04
Basophil (K/μL)0.00 ± 0.000.01 ± 0.010.01 ± 0.000.01 ± 0.01
LUC (K/μL)0.10 ± 0.040.10 ± 0.040.14 ± 0.080.13 ± 0.06
NEP (%)16.8 ± 6.216.8 ± 3.616.4 ± 3.911.5 ±
LYP (%)79.2 ± 5.878.6 ± 3.379.2 ± 3.984.6 ±
MOP (%)2.2 ± 0.92.6 ± 0.62.4 ± 0.52.1 ± 0.6
EOP (%)0.8 ± 0.30.8 ± 0.30.7 ± 0.20.6 ± 0.3
BAP (%)0.0 ± 0.10.1 ± 0.00.1 ± 0.00.1 ± 0.1
LUP (%)1.0 ± 0.41.1 ± 0.41.2 ± 0.51.0 ± 0.3
RBC (K/μL)8.81 ± 0.288.80 ± 0.448.72 ± 0.428.69 ± 0.43
Hemoglobin (g/dL)15.6 ± 0.215.2 ± 0.615.2 ± 0.615.5 ± 0.8
Hematocrit (%)45.1 ± 1.744.2 ± 1.844.1 ± 1.845.3 ± 2.7
MCV (fL)51.3 ± 1.850.2 ± 1.750.6 ± 1.552.1 ± 1.6
MCH (pg)17.8 ± 0.517.2 ± 17.4 ± 0.417.9 ± 0.5
MCHC (g/dL)34.7 ± 1.034.3 ± 0.334.4 ± 0.534.3 ± 0.7
RDW (%)12.8 ± 1.012.2 ± 0.912.6 ± 0.512.6 ± 0.5
Platelet (K/μL)1068 ± 1191015 ± 1021111 ± 1041108 ± 113
MPV (fL)6.4 ± 1.36.6 ± 1.46.5 ± 1.46.5 ± 1.5
Reticulocyte (%)2.05 ± 0.801.60 ± 0.591.85 ± 0.551.94 ± 0.33
PT (sec)9.89 ± 0.719.60 ± 0.639.39 ± 0.219.40 ± 1.01
APTT (sec)13.7 ± 2.716.0 ± 0.915.9 ± 1.315.7 ± 1.9

WBC: white blood cell; LUC: large unstained cell; NEP: percent of neutrophil; LYP: percent of lymphocyte; MOP: percent of monocyte; EOP: percent of eosinophil; BAP: percent of basophil; LUP: percent of large unstained cell; RBC: red blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red cell distribution width; MPV: mean platelet volume; PT: prothrombin time; APTT: active partial thromboplastin time. Values are expressed as mean ± SD (n = 10). < 0.05, < 0.05 compared with the control group.